-In preterm infants, both hypo-and hyperglycemia are a frequent problem. Intravenous lipids can affect glucose metabolism by stimulation of gluconeogenesis by providing glycerol, which is a gluconeogenic precursor, and/or free fatty acids (FFA), which are stimulants of the rate of gluconeogenesis. In 25 preterm infants, glucose production and gluconeogenesis were measured using stable isotope techniques during a 6-h infusion of glucose only, glucose plus glycerol, or glucose plus an intravenous lipid emulsion. Two lipid emulsions differing in FFA composition were used: Intralipid (ϳ60% polyunsaturated FFA) and Clinoleic (ϳ60% monounsaturated FFA). The rate of glucose infusion was 22 mol ⅐ kg Ϫ1 ⅐ min Ϫ1 in all groups. During the study infusion, the FFA concentrations were higher in both lipid groups vs. the glycerol group (P Ͻ 0.001). Compared with baseline, the glucose production rate increased in the Intralipid group, whereas it decreased in the other groups (P ϭ 0.002) due to a significant increase in gluconeogenesis in the Intralipid group (P ϭ 0.016). The plasma glucose concentration was significantly higher during Intralipid infusion vs. the other groups (P ϭ 0.046). Our conclusion was that Intralipid enhanced glucose production by increasing gluconeogenesis in preterm infants. This can be ascribed to the stimulatory effect of FFA in addition to any effect of glycerol alone. The lack of stimulation of gluconeogenesis in the Clinoleic vs. the Intralipid group suggests that different classes of fatty acids exert different effects on glucose kinetics in preterm infants.glycerol; fatty acids unsaturated; stable isotopes; mass isotopomer distribution analysis IN PRETERM INFANTS, disturbances in glucose metabolism are a frequent problem. Both hypo-and hyperglycemia can occur (20). Hypoglycemia occurs mostly in the first days after birth. Despite routine intravenous glucose supply, the incidence of hypoglycemia is still ϳ20% in our Neonatal Intensive Care Unit, a referral unit for infants Ͻ32 wk gestational age. Besides hypoglycemia, hyperglycemia is a mounting phenomenon in neonatal medicine, especially in sick and/or low-birth-weight infants.Free fatty acids (FFA) could play a role in the pathophysiology of both hypo-and hyperglycemia, because they are well-known stimulants of the rate of gluconeogenesis (11).Because plasma FFA concentrations in preterm infants are much lower than in adults (18,19,49), the lack of FFA could be involved in restricted capacity for gluconeogenesis, predisposing these infants for hypoglycemia. On the other hand, very preterm infants routinely receive parenteral nutrition (including gradually increasing amounts of lipids) because enteral nutrition is not tolerated in sufficient amounts. Intravenous lipid emulsions contain FFA and could, therefore, play a role in the pathophysiology of hyperglycemia in preterm infants, a mechanism comparable with those described in adults with diabetes (11).In healthy postabsorptive adults, FFA stimulate gluconeogenesis with a concomitant decrease in...